Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in Healthcare

Delta Variant Ripping Around The World At A Scorching Pace, Driving New Spike In Cases, Death: WHO

“Delta is now in more than 104 countries and we expect it to soon be the dominant COVID-19 strain circulating worldwide,” he said adding that the world is watching in real-time as the COVID-19 virus continues to change and become more transmissible.

Read More

Zydus Cadila Applies For Emergency Use Nod For COVID-19 Vaccine

An approval for Zydus' vaccine, ZyCoV-D, would make it the fifth vaccine authorized for use in India, after Moderna, AstraZeneca (AZN.L) and partner Serum Institute of India's Covishield, Bharat Biotech's Covaxin, and Sputnik V developed by Russia's Gamaleya Institute.

Read More

India's Covaxin Effectively Neutralises Delta Variant Of Covid, Says NIH

Adjuvants are substances formulated as part of a vaccine to boost immune responses and enhance a vaccine’s effectiveness.

Read More

Serum Institute Asks Govt To Take Up Inclusion Of Covishield In Vaccination Passport With EU

Only four vaccines -- Comirnaty of Pfizer/BioNTech, Moderna, Vaxzervria by AstraZeneca-Oxford and Johnson & Johnson''s Janssen -- have been approved by the European Medicines Agency (EMA) and only those vaccinated by these vaccines will be given vaccination passports and will be allowed to travel within the EU during the pandemic.

Read More

Glenmark Pharma Gets USFDA Nod For Inhalation Product

Glenmark Pharma said the Arformoterol Tartrate Inhalation Solution, 15 mcg/2 mL, Unit-Dose Vials will be manufactured in the company's North American manufacturing facility based in Monroe, North Carolina, and marks the company's first nebulizer approval.

Read More

Delta Variant 'Greatest Threat' To US' COVID-19 Efforts: Dr Fauci

“This is concerning but expected knowing what we do about how efficiently this variant spreads and by what we saw in the United Kingdom with this variant.

Read More

Russian COVID-19 Vaccine Sputnik V To Be Available In 9 More Cities Across India

The Russian vaccine's local distribution partner Dr Reddy's had also issued a statement on Wednesday saying that the project launch of Russian Covid vaccine Sputnik V has now been extended to nine other cities. Initially, it was launched only in Hyderabad.

Read More

Government Takes Steps To Ensure Availability Of Amphotericin B

In order to augment the domestic manufacture, the Government is continuously engaging with the manufacturers to resolve their issues related to raw materials.

Read More

Canada: Pfizer, Moderna Preferred 2nd Dose After AstraZeneca

On June 1, committee had said AstraZeneca recipients “could" get Pfizer or Moderna for their second shot if they wanted, but Thursday went further to say an mRNA vaccine was the ”preferred" choice.

Read More

Centre Rejects Reports Of Dissent By Experts About Increasing Gap Between Covishield Doses

The Centre on May 13 had approved extending the gap between the two doses of the Covishield vaccine from six to eight weeks to 12 to 16 weeks following a recommendation from the National Technical Advisory Group on Immunisation (NTAGI).

Read More

India Cuts Taxes On Medicines And Equipment To Treat COVID-19

The government cut taxes on medical grade oxygen, ventilators, the remdesivir antiviral drug, diagnostic kits, pulse oximeters and hand sanitizers to 5% from 12-18% with immediate effect.

Read More

Covishield produces more antibodies than Covaxin, finds study

The yet-to-be-published study, posted on the preprint repository MedRxiv on June 4, covered 515 healthcare workers (HCW) -- 305 men and 210 women -- from 22 cities in 13 states.

Read More

Vaccine Economy: The Jab Tab

It would cost India anywhere between Rs 35,000 crore and Rs 3.7 lakh crore to vaccinate its billion-plus people depending on who is buying the doses, at what price and from where?

Read More

Eli Lilly Gets Indian Emergency Use Nod For COVID-19 Antibody Drug Combination

Monoclonal antibodies mimic natural antibodies that the body generates to fight infection.

Read More

India's Biological E. To Make Providence Therapeutics' mRNA COVID-19 Vaccine

Providence will sell up to 30 million doses of its mRNA vaccine, PTX-COVID19-B, to Biological E., and will also provide the necessary technology transfer of the shot, with a minimum production capacity of 600 million doses in 2022 and a target capacity of 1 billion doses.

Read More